BUY CG Power and Industrial Solutions Ltd. — Manas Jaiswal
byManas JaiswalHorizon: NA (inferred Swing (≤2wk))15 Jul 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
4 advisors have active short-term BUY calls on this stock, with 3 issued in the last 14 days
Advisor consensus · adjacent horizon·16 Jul · today
2 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days
Advisor consensus · same horizon·15 Jul · today
CG Semi has commenced commercial production at its new G1 OSAT facility in Sanand, Gujarat, marking a significant step in its manufacturing capabilities and expansion.
NSE · Press Release·4 Jul · 2w ago
CG Semi, a subsidiary of CG Power, has commenced commercial production at its G1 OSAT facility in Sanand, Gujarat. This facility has a peak capacity of up to 300 million units per year and is part of
BSE · Company Update·4 Jul · 2w ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on CG Power and Industrial Solutions
- BUY — IDBI Capital23 Oct 2026 · ~2 weeks · target ₹830 · SL hit
- BUY — Ansh Jogendra Bhilwar22 Oct 2026 · ~1 year · target ₹912 · SL hit
- BUY — Kunal Parar, Choice Broking16 Oct 2026 · ~2 weeks · target ₹920 · SL hit
- BUY — Rachit Khandelwal14 Oct 2026 · ~1 year · target ₹960 · Active
- SELL — Manas Jaiswal8 Oct 2026 · ~2 weeks · target ₹825 · Target hit
More from Manas Jaiswal
- BUY Ajanta Pharma23 Oct 2026 · Same day · target ₹3,425 · SL hit
- BUY Torrent Pharmaceuticals23 Oct 2026 · Same day · target ₹4,725 · SL hit
- BUY SAGILITY23 Oct 2026 · ~2 weeks · target ₹50 · SL hit
- BUY Zydus Lifesciences22 Oct 2026 · ~3 months · target ₹1,160 · SL hit
- BUY IPCA Laboratories22 Oct 2026 · ~2 weeks · target ₹2,000 · Active

